For much of 2020 and 2021, the pharmaceutical stock investment thesis revolved around development and disbursement of coronavirus vaccines. While that made for an obvious catalyst, and a rewarding one at that, the effects of the COVID-19 vaccine status as an accelerant for pharma equities waned this year. Fortunately, exchange traded funds such as the [...] The post Growth, Innovation Could Fuel Pharma ETF Rebound appeared first on ETF Trends .